Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa

被引：50
作者：
Renau, TE
Léger, R
Flamme, EM
She, MW
Gannon, CL
Mathias, KM
Lomovskaya, O
Chamberland, S
Lee, VJ
Ohta, T
Nakayama, K
Ishida, Y
机构：
[1] Microcide Pharmaceut Inc, Mountain View, CA 94043 USA
[2] Daiichi Pharmaceut Co Ltd, New Prod Res Labs 1, Tokyo 1348630, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 05期
关键词：
D O I：
10.1016/S0960-894X(01)00033-6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Synthetic optimization of a biologically labile class of dipeptides that function as efflux pump inhibitors to potentiate the antibacterial agent levofloxacin in Pseudomonas aeruginosa has led to the discovery of a related series of compounds that are completely stable in a variety of biological matrices. Other than the stability profile, the in vitro profile of the new series is essentially identical to that observed with the original one. A prototypical compound from the new series demonstrates potentiation in an in vivo model of infection. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：663 / 667
页数：5
相关论文
共 11 条
[1]  
BRENNAN L, 1998, 38 INT C ANT AG CHEM
[2]  
Lawrence L E, 1998, Expert Opin Investig Drugs, V7, P199, DOI 10.1517/13543784.7.2.199
[3]   ACTIVE EFFLUX MECHANISMS FOR ANTIMICROBIAL RESISTANCE [J].
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :695-703
[4]   Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa [J].
Lomovskaya, O ;
Lee, A ;
Hoshino, K ;
Ishida, H ;
Mistry, A ;
Warren, MS ;
Boyer, E ;
Chamberland, S ;
Lee, VJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1340-1346
[5]   Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:: Novel agents for combination therapy [J].
Lomovskaya, O ;
Warren, MS ;
Lee, A ;
Galazzo, J ;
Fronko, R ;
Lee, M ;
Blais, J ;
Cho, D ;
Chamberland, S ;
Renau, T ;
Leger, R ;
Hecker, S ;
Watkins, W ;
Hoshino, K ;
Ishida, H ;
Lee, VJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :105-116
[6]   MOLECULAR REQUIREMENTS FOR THE INHIBITION OF THE TETRACYCLINE ANTIPORT PROTEIN AND THE EFFECT OF POTENT INHIBITORS ON THE GROWTH OF TETRACYCLINE-RESISTANT BACTERIA [J].
NELSON, ML ;
PARK, PH ;
LEVY, SB .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (09) :1355-1361
[7]   Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria [J].
Poole, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2233-2241
[8]   Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin [J].
Renau, TE ;
Léger, R ;
Flamme, EM ;
Sangalang, J ;
She, MW ;
Yen, R ;
Gannon, CL ;
Griffith, D ;
Chamberland, S ;
Lomovskaya, O ;
Hecker, SJ ;
Lee, VJ ;
Ohta, T ;
Nakayama, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) :4928-4931
[9]  
RENAU TE, 1998, ANNU REP MED CHEM, V33, P121, DOI DOI 10.1016/S0065-7743(08)61077-5
[10]   IN-VITRO AND IN-VIVO ANTIBACTERIAL ACTIVITIES OF THE GLYCYLCYCLINES, A NEW CLASS OF SEMISYNTHETIC TETRACYCLINES [J].
TESTA, RT ;
PETERSEN, PJ ;
JACOBUS, NV ;
SUM, PE ;
LEE, VJ ;
TALLY, FP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2270-2277
12